Marc A. Kedde

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Bart C. Kuenen, Lee S. Rosen, Egbert F. Smit et al. · Journal of Clinical Oncology · 2002 · 140 citations

Pharmacy, Oncology, Pharmacology +17

A phase I study of monohydroxyethylrutoside in healthy volunteers

Anja M. Willems, A. Bruynzeel, Marc A. Kedde et al. · Cancer Chemotherapy and Pharmacology · 2005 · 29 citations

Medicine, Pharmacokinetics, Pharmacology +3

The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG

Miranda Verschraagen, Marc A. Kedde, Frederick H. Hausheer et al. · Cancer Chemotherapy and Pharmacology · 2003 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice

Mohamed Hassan, Marc A. Kedde, Ursula T. H. Zwiers et al. · Cancer Chemotherapy and Pharmacology · 2003 · 16 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

Mohamed Hassan, Marc A. Kedde, Ursula T. H. Zwiers et al. · Cancer Chemotherapy and Pharmacology · 2003 · 12 citations

Medicine, Pharmacokinetics, Pharmacology +11